At the pulse of heart disease
We are pioneers in the discovery and development of non-coding RNA-based therapeutics designed to address the root causes of heart disease.
Oligonucleotide Therapeutics Xchange
Event · June 27, 2023 · Brusells, Belgium
Jefferies Healthcare Conference 2023
Event · June 8–9, 2023 · New York NY, USA
CDR132L featured in Nature Biotechnology
Cardior's lead candidate CDR132L is featured in the article "Genetic medicines aim straight for the heart" by Corman Sheridan published in Nature Biotechnology on April 04, 2023.
Cardior News · April 17, 2023